Advertisement
Canada markets closed
  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • Bitcoin CAD

    83,162.09
    -3,136.73 (-3.63%)
     
  • CMC Crypto 200

    1,262.26
    -95.75 (-7.05%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     
  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     

Company News for Nov 8, 2022

  • Shares of Haemonetics Corp. HAE advanced 3.6% after reporting second-quarter fiscal 2022 adjusted earnings per share of $0.83, surpassing the Zacks Consensus Estimate of $0.70.

  • Shares of Affiliated Managers Group Inc. AMG soared 11.4% after posting third-quarter 2023 adjusted earnings per share of $4.21, outpacing the Zacks Consensus Estimate of $3.92.  

  • NiSource Inc.’s NI shares tumbled 5.9% after the company reported third-quarter 2022 adjusted earnings per share of $0.10, missing the Zacks Consensus Estimate of $0.11.

  • Palantir Technologies Inc.’s PLTR shares plunged 11.5% after the company posted third-quarter 2022 adjusted earnings per share of $0.01, lagging the Zacks Consensus Estimate of $0.02.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
NiSource, Inc (NI) : Free Stock Analysis Report
 
Haemonetics Corporation (HAE) : Free Stock Analysis Report
 
Affiliated Managers Group, Inc. (AMG) : Free Stock Analysis Report
 
Palantir Technologies Inc. (PLTR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research